Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes: Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children
- PMID: 38363973
- PMCID: PMC10973904
- DOI: 10.2337/dc23-1671
Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes: Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children
Abstract
Objective: To examine the prevalence and predictive factors for celiac disease (CD) after a diagnosis of type 1 diabetes (T1D) in children and adolescents, to improve the current screening guidelines.
Research design and methods: The association between sex, age at T1D diagnosis, HLA, and diabetes autoantibodies, and a diagnosis of CD was examined in 5,295 children with T1D from the Better Diabetes Diagnosis study in Sweden.
Results: The prevalence of biopsy-proven CD was 9.8%, of which 58.2% already had a CD diagnosis before or at T1D onset. Almost all, 95.9%, were diagnosed with CD within 5 years after the T1D diagnosis. Younger age at the T1D diagnosis and being homozygote for DQ2 increased the risk of CD after T1D, but neither sex nor diabetes-related autoantibodies were associated with the risk.
Conclusions: Age at and time after diabetes diagnosis should be considered in screening guidelines for CD in children with T1D.
© 2024 by the American Diabetes Association.
Conflict of interest statement
Figures
References
-
- Fröhlich-Reiterer E, Elbarbary NS, Simmons K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 2022;23:1451–1467 - PubMed
-
- Persson M, Becker C, Elding Larsson H, et al. The Better Diabetes Diagnosis (BDD) study—a review of a nationwide prospective cohort study in Sweden. Diabetes Res Clin Pract 2018;140:236–244 - PubMed
-
- American Diabetes Association Professional Practice Committee . 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45(Suppl. 1):S17–S38 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
